JUPITER, Fla. and LELAND, N.C., Feb. 13, 2024 (GLOBE NEWSWIRE) -- Dyadic International Inc. (œDyadic, or the œCompany) (Nasdaq: DYAI) and Cygnus Technologies®, part of Maravai LifeSciences®...
LELAND, N.C., Aug. 23, 2023 (GLOBE NEWSWIRE) -- Cygnus Technologies, part of Maravai LifeSciences (Maravai) (NASDAQ: MRVI), the leading product and services provider for the detection and...
SOUTHPORT, N.C., Nov. 07, 2022 (GLOBE NEWSWIRE) -- Cygnus Technologies, part of Maravai LifeSciences (Maravai) (NASDAQ: MRVI), the leading assay and services provider for the detection and characterization of process-related impurities in biopharmaceuticals, announced today the launch of the MockV® RVLP Kit. This kit enables bioprocess scientists to quantify the removal of Retrovirus-Like Particles (RVLPs) produced endogenously by Chinese Hamster Ovary (CHO) cell lines during biopharmaceutical manufacturing. The kit includes a highly purified and concentrated stock solution of RVLPs along with the necessary reagents for accurate and reliable RVLP quantification.
Medpho, a healthcare technology startup, has raised US$ 1 million in an angel funding round, led by Cygnus Medicare Group, Probal Ghoshal, chairman, Amar Ujala, Dr Shuchin Bajaj, founder & director of Ujala Cygnus and Raghavendra Prasad, founder, Project StepOne. With the received funding, the startup aims to focus on strengthening company’s position in the market, expansion, innovation and provide complete healthcare services to rural and urban consumers.